DuPont Decomposition

Why does GPTHEALTH earn its ROE?

Breaking down Return on Equity into profitability, efficiency, and leverage.

ROE = Net Margin × Asset Turnover × Equity Multiplier

15.7% = 8.9% × 1.02 × 1.72

Latest: FY2026

Profitability

Net Margin

8.9%

12.4% →8.9%

How much profit per ₹ of revenue

Efficiency

Asset Turnover

1.02x

1.04x →1.02x

Revenue per ₹ of assets

Leverage

Equity Multiplier

1.72x

2.04x →1.72x

Assets funded by equity vs debt

Trend Analysis

ROE declined by 10.7 pp over 5 years. Driven by net margin declining (12.4% → 8.9%), leverage falling (2.04x → 1.72x).

Historical Decomposition

Last 5 years

YearRevenuePATNet MarginAsset TOLeverageROE
FY20220Cr0Cr12.4%1.042.0426.3%
FY20230Cr0Cr10.8%1.101.9823.6%
FY20240Cr0Cr12.0%1.161.5821.9%
FY20250Cr0Cr12.3%1.061.5520.1%
FY20260Cr0Cr8.9%1.021.7215.7%

How to read DuPont

  • Rising ROE from margin = pricing power, operational improvement (good)
  • Rising ROE from turnover = better asset utilization (good)
  • Rising ROE from leverage = more debt, amplified risk (caution)
  • Falling ROE across all three = structural deterioration (red flag)

See DCF fair value for GPTHEALTH

Combine financial quality with intrinsic value.

See Fair Value →

DuPont decomposition from audited annual financials. Factual analysis, not investment advice.

GPTHEALTH DuPont Analysis — ROE 15.7% | YieldIQ